These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 9355668

  • 1. Bisphosphonates: pharmacology and effects on the growing skeleton.
    Papapoulos SE.
    Acta Univ Carol Med (Praha); 1994; 40(1-4):29-32. PubMed ID: 9355668
    [No Abstract] [Full Text] [Related]

  • 2. Effects of pharmacologic agents on bone in childhood: an editorial overview.
    Klein GL, Bachrach LK, Holm IA.
    Pediatrics; 2007 Mar; 119 Suppl 2():S125-30. PubMed ID: 17332231
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The pharmacology and therapeutic utility of bisphosphonates.
    Lourwood DL.
    Pharmacotherapy; 1998 Mar; 18(4):779-89. PubMed ID: 9692651
    [Abstract] [Full Text] [Related]

  • 5. Effect of denosumab on the growing skeleton in osteogenesis imperfecta.
    Hoyer-Kuhn H, Semler O, Schoenau E.
    J Clin Endocrinol Metab; 2014 Nov; 99(11):3954-5. PubMed ID: 25148238
    [No Abstract] [Full Text] [Related]

  • 6. Current controversies in bisphosphonate therapy.
    Paul GR.
    Orthopedics; 2010 Jul; 33(7):468. PubMed ID: 20608598
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The in vivo anabolic actions of prostaglandins in bone.
    Jee WS, Ma YF.
    Bone; 1997 Oct; 21(4):297-304. PubMed ID: 9315332
    [No Abstract] [Full Text] [Related]

  • 10. Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats.
    Hornby SB, Evans GP, Hornby SL, Pataki A, Glatt M, Green JR.
    Calcif Tissue Int; 2003 Apr; 72(4):519-27. PubMed ID: 12574877
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Bisphosphonates prevent experimental vascular calcification: Treat the bone to cure the vessels?
    Persy V, De Broe M, Ketteler M.
    Kidney Int; 2006 Nov; 70(9):1537-8. PubMed ID: 17051257
    [Abstract] [Full Text] [Related]

  • 14. [Mechanisms for anti-resorptive action of bisphosphonates in bone diseases].
    Bałczewska E, Bałczewski P.
    Postepy Biochem; 2001 Nov; 47(4):328-36. PubMed ID: 12046265
    [No Abstract] [Full Text] [Related]

  • 15. [Preclinical toxicology of bisphosphonates].
    Mondelo N, Peluffo VA, Parma MD, Cointry GR, Capozza RF, Ferretti JL, Piccinni E, Montuori E.
    Medicina (B Aires); 1997 Nov; 57 Suppl 1():93-100. PubMed ID: 9567361
    [Abstract] [Full Text] [Related]

  • 16. Epi- and metaphyseal changes in children caused by administration of bisphosphonates.
    van Persijn van Meerten EL, Kroon HM, Papapoulos SE.
    Radiology; 1992 Jul; 184(1):249-54. PubMed ID: 1609087
    [Abstract] [Full Text] [Related]

  • 17. [Inhibitors of HMG-CoA reductase in prevention of osteoporosis and bone fractures. Similar mechanism of action of statins and bisphosphonates].
    Stajszczyk M, Mykała-Cieśla J.
    Pol Arch Med Wewn; 2002 Jan; 107(1):85-91. PubMed ID: 12046350
    [No Abstract] [Full Text] [Related]

  • 18. [The use of bisphosphonates for treating pathological states in orthopedics].
    Białecki P, Bohatyrewicz A, Machoy-Mokrzyńska A, Białecka M.
    Chir Narzadow Ruchu Ortop Pol; 2008 Jan; 73(4):266-73. PubMed ID: 18847019
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The importance of growth hormone (GH) and GH secretagogues for bone mass and density.
    Svensson J.
    Curr Pharm Des; 2002 Jan; 8(23):2023-32. PubMed ID: 12171516
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.